SARS-CoV-2 Reagents and Services Related Citations

The COVID-19 pandemic, caused by SARS-CoV-2 virus, has resulted in unprecedented crisis to the global health. A timely response to virus outbreaks in terms of the developments of both diagnostic tools and therapeutics is essential to combat such invisible enemies. To support these studies, Sino Biological has developed a comprehensive panel of antibodies and antigens for SARS-CoV-2. Sino Biological also specializes in recombinant antigen and antibody production. The ProVirTM collection is the world largest viral antigen bank, including over 800 proteins from 350 viral strains.

Up to 30th April, there are near 500 publised papers and 120 pre-publised publications that have cited SARS-CoV-2 reagents or services providing by Sino Biological Inc.

Partial list of SARS-CoV-2 products cited in publications

Cat# Molecule Tag Expressed Host
40592-V08H6 Spike RBD Mutant,F342L His tag HEK293 Cells
40592-V08H7 Spike RBD Mutant,K458R His tag HEK293 Cells
40592-V08H1 Spike RBD Mutant,V367F His tag HEK293 Cells
40592-V08H2 Spike RBD Mutant,N354D His tag HEK293 Cells
40592-V08H4 Spike RBD Mutant,A435S His tag HEK293 Cells
40592-V08H5 Spike RBD Mutant,V483A His tag HEK293 Cells
40592-V08H8 Spike RBD Mutant,G476S His tag HEK293 Cells
40592-V08H9 Spike RBD Mutant,W436R His tag HEK293 Cells
40592-V08H59 Spike RBD Mutant,K417N(B.1.351) His tag HEK293 Cells
40592-V08H46 Spike RBD Mutant,S477N His tag HEK293 Cells
40592-V08H14 Spike RBD Mutant,N439K His tag HEK293 Cells
40591-V08H3 Spike RBD Mutant,D614G His tag, HPLC-verified HEK293 Cells
40592-V05H Spike RBD mFc tag, HPLC-verified HEK293 Cells
40592-V08B Spike RBD His tag Baculovirus-Insect Cells
40592-V08H Spike RBD His tag HEK293 Cells
40592-V08B-B Spike RBD His tag Baculovirus-Insect Cells
40592-V02H Spike RBD Fc tag HEK293 Cells
40592-V31H Spike RBD rFc Tag HEK293 Cells
40592-VNAH Spike RBD HEK293 Cells
40591-V08H Spike S1 His tag, HPLC-verified HEK293 Cells
40591-V02H Spike S1 His tag HEK293 Cells
40591-V08B1 Spike S1 His tag Baculovirus-Insect Cells
40591-V05H1 Spike S1 mFc Tag HEK293 Cells
40591-V49H Spike S1 NTD His & AVI HEK293 Cells
40591-V41H Spike S1 NTD Fc & AVI HEK293 Cells
40589-V08B1 Spike S1+S2 ECD His tag Baculovirus-Insect Cells
40589-V27B-B Spike S1+S2 ECD AVI & His tag, Biotinylated Baculovirus-Insect Cells
40590-V08B Spike S2 His tag Baculovirus-Insect Cells
40590-V05B Spike S2 mFc tag Baculovirus-Insect Cells
40588-V08B Nucleocapsid His tag Baculovirus-Insect Cells
40588-V27B-B Nucleocapsid AVI & His, Biotinylated Baculovirus-Insect Cells
40588-V07E Nucleocapsid His tag E. coli
40598-V07E CoV-ME His tag E. coli
40593-V07E PLpro His tag E.coli
Cat# Description Type Application
40143-MM05 SARS-CoV / SARS-CoV-2 Nucleocapsid Antibody Mouse MAb WB, ELISA
40143-MM08 SARS-CoV / SARS-CoV-2 Nucleocapsid Antibody Mouse MAb WB, ELISA
40143-R001 SARS-CoV / SARS-CoV-2 Nucleocapsid Antibody Rabbit MAb WB, ELISA
40143-R004 SARS-CoV / SARS-CoV-2 Nucleocapsid Antibody Rabbit MAb WB, ELISA
40143-R019 SARS-CoV / SARS-CoV-2 Nucleocapsid Antibody Rabbit MAb WB, ELISA
40143-R040 SARS-CoV / SARS-CoV-2 Nucleocapsid Antibody Rabbit MAb WB, ELISA
40143-T62 SARS-CoV / SARS-CoV-2 Nucleoprotein / NP Antibody, Antigen Affinity Purified Rabbit PAb WB, ELISA
40150-D001 SARS-CoV / SARS-CoV-2 Spike antibody Chimeric MAb ELISA, Neutralization
40150-D002 SARS-CoV / SARS-CoV-2 Spike antibody Chimeric MAb ELISA, Neutralization
40150-D003 SARS-CoV / SARS-CoV-2 Spike antibody Chimeric MAb ELISA
40150-D004 SARS-CoV / SARS-CoV-2 Spike antibody Chimeric MAb ELISA
40150-D006 SARS-CoV / SARS-CoV-2 Spike Antibody Chimeric MAb ELISA
40150-R007 SARS-CoV / SARS-CoV-2 Spike Antibody Rabbit MAb ELISA
40150-T62-CoV2 SARS-CoV / SARS-CoV-2 Spike Antibody, Antigen Affinity Purified Rabbit PAb WB, ELISA
40588-R0004 SARS-CoV-2 Nucleocapsid Antibody Rabbit MAb WB, ELISA
40588-T62 SARS-CoV-2 Nucleocapsid Antibody, Antigen Affinity Purified Rabbit PAb WB, ELISA
40589-T62 SARS-CoV-2 Spike Antibody, Antigen Affinity Purified Rabbit PAb WB, ELISA
40590-D001 SARS-CoV-2 Spike S2 Antibody Chimeric MAb ELISA
40590-T62 SARS-CoV-2 Spike S2 Antibody, Antigen Affinity Purified Rabbit PAb WB, ELISA
40591-MM42 SARS-CoV-2 Spike Antibody Mouse Mab WB, ELISA
40591-MM43 SARS-CoV-2 Spike Neutralizing Antibody Mouse Mab ELISA, Neutralization
40591-T62 SARS-CoV-2 Spike Antibody, Antigen Affinity Purified Rabbit PAb WB, ELISA
40592-MM57 SARS-CoV-2 Spike Neutralizing Antibody Mouse Mab ELISA, Neutralization
40592-MP01 SARS-CoV-2 Spike RBD Antibody, Mouse PAb Mouse PAb ELISA
40592-R001 SARS-CoV-2 Spike Neutralizing Antibody Rabbit Mab ELISA, Neutralization
40592-T62 SARS-CoV-2 Spike RBD Antibody, Antigen Affinity Purified Rabbit PAb WB, ELISA
Product Type Cat# Description
Pseudovirus PSV001 SARS-CoV-2 (2019-nCoV) Spike Pseudovirus
ELISA KIT40591 SARS-CoV-2 (2019-nCoV) Spike ELISA Kit
ELISA kit40588 SARS-CoV-2 (2019-nCoV) Nucleocapsid ELISA Kit
ELISA kit005 SARS-CoV-2 (2019-nCoV) Nucleocapsid/N Antibody Titer Assay Kit
ELISA kit004 SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD Antibody Titer Assay Kit
Gene VG40150-G-N Human SARS coronavirus (SARS-CoV) Spike glycoprotein Gene ORF cDNA clone expression plasmid (Codon Optimized)
Gene VG40589-UT SARS-CoV-2 (2019-nCoV) Spike Gene ORF cDNA clone expression plasmid (Codon Optimized)
Gene HG10108-UT Human ACE2 / Angiotensin-Converting Enzyme 2 Gene ORF cDNA clone expression plasmid
Gene VG40592-CH SARS-CoV-2 (2019-nCoV) Spike RBD Gene ORF cDNA clone expression plasmid, C-His tag (Codon Optimized)
Gene HG10108-ACR ACE2 cDNA ORF Clone, Human, C-OFPSpark® tag
Gene VG40069-G-N MERS-CoV Spike Protein Gene ORF cDNA clone expression plasmid (Codon Optimized)
Gene VG40588-UT SARS-CoV-2 Nucleocapsid ORF mammalian expression plasmid (Codon Optimized)
Gene VG40591-CH SARS-CoV-2 Spike S1 Gene ORF cDNA clone expression plasmid, C-His tag (Codon Optimized)
Gene VG40588-CH SARS-CoV-2 Nucleoprotein Gene ORF cDNA clone expression plasmid, C-His tag (Codon Optimized)
Gene VG40589-NM SARS-CoV-2 Spike Gene ORF cDNA clone expression plasmid, N-Myc tag (Codon Optimized)
Cat# Molecule Tag Expressed Host
10108-H08H ACE2 His tag, HPLC-verified HEK293 Cells
10108-H02H ACE2 Fc tag HEK293 Cells
10108-H05H ACE2 Fc tag HEK293 Cells
10108-H08B ACE2 His tag, HPLC-verified Baculovirus-Insect Cells
10108-H08H-B ACE2 His tag, Biotinylated HEK293 Cells
90211-C02H ACE2 Fc Tag HEK293 Cells

Partial list of Citations cited Sino Biological's SARS-CoV-2 Reagents

• Dan, JM, et al.Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.Science (New York, N.Y.).2021

• Thomson, E, et al.Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.Cell.2021

• Brouwer, PJM, et al.Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.Cell.2021

• Dejnirattisai, W, et al.The antigenic anatomy of SARS-CoV-2 receptor binding domain.Cell.2021

• Mills, R, et al.BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.Cell.2021

• Ren, X, et al.COVID-19 immune features revealed by a large-scale single cell transcriptome atlas.Cell.2021

• Asarnow, D, et al.Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.Cell.2021

• Zhou, D, et al.Robust SARS-CoV-2 Infection in Nasal Turbinates after Treatment with Systemic Neutralizing Antibodies.Cell Host & Microbe.2021

• Sakharkar, M, et al.Prolonged evolution of the human B cell response to SARS-CoV-2 infection.Science immunology.2021

• Routhu, N, et al.Modified Vaccinia Ankara Vector-Based Vaccine Protects Macaques from SARS-CoV-2 Infection, Immune Pathology and Dysfunction in the Lung.Immunity.2021

• Wang, C, et al.ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.Cell Stem Cell.2021

• Kim, SI, et al.Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in COVID-19 patients and healthy individuals.Science translational medicine.2021

• Yan, B, et al.SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.Science immunology.2021

• Zhao, M, et al.GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein.Nature communications.2021

• Ferreira-Gomes, M, et al.SARS-CoV-2 in severe COVID-19 induces a TGF-尾-dominated chronic immune response that does not target itself.Nature communications.2021

• Becker, M, et al.Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.Nature communications.2021

• Wheatley, AK, et al.Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.Nature communications.2021

• van Kampen, JJA, et al.Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).Nature communications.2021

• Zhang, C, et al.Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections.Nature communications.2021

• Ge, J, et al.Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry.Nature communications.2021

• Ku, Z, et al.Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.Nature communications.2021

• Fu, Z, et al.The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery.Nature communications.2021

• Kim, C, et al.A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.Nature communications.2021

• Zhu, Y, et al.A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry.Nature communications.2021

• Jiang, XL, et al.Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.Nature communications.2021

• Ozono, S, et al.SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.Nature communications.2021

• Bertoglio, F, et al.SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface.Nature communications.2021

• Yan, H, et al.ACE2 receptor usage reveals variation in susceptibility to SARS-CoV and SARS-CoV-2 infection among bat species.Nature ecology & evolution.2021

• Li, J, et al.Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study.Nature medicine.2021

• Shan, H, et al.Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2.Cell Chemical Biology.2021

• Zhang, Z, et al.SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination.Cell death and differentiation.2021

• Nie, J, et al.Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses.Cell discovery.2021

• Lu, S, et al.The immunodominant and neutralization linear epitopes for SARS-CoV-2.Cell reports.2021

• Cotugno, N, et al.Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies.Cell reports.2021

• Hoffmann, M, et al.SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization.Cell Reports.2021

• Song, E, et al.Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms.Cell Reports Medicine.2021

• Piepenbrink, MS, et al.Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters.Cell reports. Medicine.2021

• Harrington, WE, et al.Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19 disease.Cell reports. Medicine.2021

• Liu, J, et al.The m6A methylome of SARS-CoV-2 in host cells.Cell research.2021

• Shao, W, et al.Rapid Detection of SARS-CoV-2 Antigens Using High-Purity Semiconducting Single-Walled Carbon Nanotube-Based Field-Effect Transistors.ACS applied materials & interfaces.2021

• Wang, C, et al.Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone.ACS infectious diseases.2021

• Kang, YF, et al.Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates.ACS nano.2021

• Kim, S, et al.Vertical Flow Cellulose-Based Assays for SARS-CoV-2 Antibody Detection in Human Serum.ACS sensors.2021

• Gray, KJ, et al.COVID-19 vaccine response in pregnant and lactating women: a cohort study.American journal of obstetrics and gynecology.2021

• SHERER, M, et al.Pregnancy alters IL-1尾 expression and anti-viral antibody responses during SARS-CoV-2 infection.American Journal of Obstetrics and Gynecology.2021

• Lv, Y, et al.Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach.Analytical and bioanalytical chemistry.2021

• Ramirez, S, et al.Overcoming culture restriction for SARS-CoV-2 in human cells facilitates the screening of compounds inhibiting viral replication.Antimicrobial agents and chemotherapy.2021

• Vogel, M, et al.Molecular definition of SARS-CoV-2 RBD mutations: receptor affinity versus neutralization of receptor interaction.authorea.2021

• Thieme, C, et al.Detection of SARS-CoV-2 Specific Memory B cells to Delineate Long-Term COVID-19 Immunity.Authorea.2021

• Biagioli, M, et al.Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction.Biochemical pharmacology.2021

• Chen, W, et al.Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate.Biochimica et Biophysica Acta (BBA) - General Subjects.2021

• Cao, W, et al.Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.Biophysical journal.2021

• Ahmadivand, A, et al.Functionalized terahertz plasmonic metasensors: Femtomolar-level detection of SARS-CoV-2 spike proteins.Biosensors & bioelectronics.2021

• Yang, HS, et al.Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients.Biosensors & bioelectronics.2021

• Taha Azad, , et al.SARS-CoV-2 S1 NanoBiT: a Nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition.Biosensors and Bioelectronics.2021

• Singh, N, et al.Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer.Biosensors and Bioelectronics.2021

• Demers-Mathieu, V, et al.Comparison of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies\' Binding Capacity Between Human Milk and Serum from Coronavirus Disease 2019-Recovered Women.Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.2021

• Oh, S, et al.SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.Cells.2021

• Legros, V, et al.A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.Cellular & molecular immunology.2021

• Hou, Y, et al.Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis.Chemico-biological interactions.2021

• Yang, J, et al.Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study.Clinical & Translational Immunology.2021

• Pandey, M, et al.Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2.Clinical & translational immunology.2021

• Sharma, P, et al.Pathology of COVID 19 associated acute kidney injury.Clinical Kidney Journal.2021

• Pedrosa, MA, et al.Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19.Clinical science (London, England : 1979).2021

• Dogan, M, et al.SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus.Communications biology.2021

• Karoyan, P, et al.Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection.Communications biology.2021

• Li, X, et al.Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification.Computational and structural biotechnology journal.2021

• Márquez-Ipiña, AR, et al.Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBDN318-V510) Expressed in Escherichia coli.Diagnostics (Basel, Switzerland).2021

• Perrucci, GL, et al.Presence of SARS-CoV-2 Nucleoprotein in Cardiac Tissues of Donors with Negative COVID-19 Molecular Tests.Diagnostics (Basel, Switzerland).2021

• Zhan, Y, et al.Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro.Drug development research.2021

• Klausberger, M, et al.A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests.EBioMedicine.2021

• Mykytyn, AZ, et al.SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site.eLife.2021

• Wagner, TR, et al.NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies.EMBO reports.2021

• Wang, L, et al.Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses.Emerging infectious diseases.2021

• Brustolin, M, et al.Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.Emerging microbes & infections.2021

• Hewawaduge, C, et al.Copper-impregnated three-layer mask efficiently inactivates SARS-CoV2.Environmental Research.2021

• Kim, E, et al.A Single Subcutaneous or Intranasal Immunization with Adenovirus-Based SARS-CoV-2 Vaccine Induces Robust Humoral and Cellular Immune Responses in Mice.European journal of immunology.2021

• Ge, S, et al.Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2.European journal of pharmacology.2021

• Xiong, Y, et al.Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening.Fitoterapia.2021

• Jeong, H, et al.A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.Frontiers in Immunology.2021

• Yuen, RR, et al.Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection.Frontiers in immunology.2021

• Lai, Y, et al.Immune profiles of a COVID-19 adolescent with mild symptoms and anti-viral antibody deficiency.Fundamental Research.2021

• Alandijany, T, et al.Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia.Healthcare.2021

• Oishee, MJ, et al.COVID-19 Pandemic: Review of Contemporary and Forthcoming Detection Tools.Infection and drug resistance.2021

• Oshiro, S, et al.Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction.International dairy journal.2021

• Noy-Porat, T, et al.Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice.iScience.2021

• Dwyer, C, et al.Comparative Analysis of Antibodies to SARS-CoV-2 between Asymptomatic and Convalescent Patients.iScience.2021

• Kiseleva, AA, et al.SARS-CoV-2 spike protein binding selectively accelerates substrate-specific catalytic activity of ACE2.Journal of biochemistry.2021

• O'Keefe, S, et al.Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor.Journal of cell science.2021

• Onodi, F, et al.SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.Journal of Experimental Medicine.2021

• Krähling, V, et al.Development and characterization of an indirect ELISA to detect SARS-CoV - 2 spike protein-specific antibodies.Journal of immunological methods.2021

• Alharbi, N, et al.Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia.Journal of Infection and Public Health.2021

• Balkrishna, A, et al.Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction.Journal of inflammation research.2021

• Ahmed, WA, et al.Seroprevalence of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers in Makkah, Saudi Arabia.Journal of King Saud University. Science.2021

• He, J, et al.SARS-CoV-2 nucleocapsid protein intranasal inoculation induces local and systemic T cell responses in mice.Journal of medical virology.2021

• Valdespino-Vázquez, MY, et al.Fetal and placental infection with SARS-CoV-2 in early pregnancy.Journal of medical virology.2021

• Hu, S, et al.Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.Journal of medical virology.2021

• Li, Y, et al.Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models.Journal of medicinal chemistry.2021

• Demers-Mathieu, V, et al.Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43.Journal of perinatology : official journal of the California Perinatal Association.2021

• Miller, LM, et al.Heterogeneity of Glycan Processing on Trimeric SARS-CoV-2 Spike Protein Revealed by Charge Detection Mass Spectrometry.Journal of the American Chemical Society.2021

• Deinhardt-Emmer, S, et al.SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.Journal of virology.2021

• Yu, J, et al.Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.Journal of virology.2021

• de Vries, M, et al.A comparative analysis of SARS-CoV-2 antivirals characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19.Journal of virology.2021

• Chen, M, et al.Nanotraps for the containment and clearance of SARS-CoV-2.Matter.2021

• Pradenas, E, et al.Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes.Med (New York, N.Y.).2021

• Verma, S, et al.SARS-CoV-2 colonization of maternal and fetal cells of the human placenta promotes alteration of local renin-angiotensin system.Med (New York, N.Y.).2021

• Wang, X, et al.Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro.Microbial pathogenesis.2021

• Qu, J, et al.A Microflow Cytometry-Based Agglutination Immunoassay for Point-of-Care Quantitative Detection of SARS-CoV-2 IgM and IgG.Micromachines.2021

• Stefanik, M, et al.Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2.Microorganisms.2021

• Joyraj Bhattacharjee, M, et al.Identifying primate ACE2 variants that confer resistance to SARS-CoV-2.Molecular biology and evolution.2021

• Azad, T, et al.Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 Spike for viral entry.Molecular therapy : the journal of the American Society of Gene Therapy.2021

• de Alwis, R, et al.A Single Dose of Self-Transcribing and Replicating RNA Based SARS-CoV-2 Vaccine Produces Protective Adaptive Immunity In Mice.Molecular therapy : the journal of the American Society of Gene Therapy.2021

• Capone, S, et al.Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19.Molecular therapy : the journal of the American Society of Gene Therapy.2021

• Lau, WL, et al.The COVID-Kidney Controversy: Can SARS-CoV-2 Cause Direct Renal Infection?.Nephron.2021

• Miller, CJ, et al.FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein.New biotechnology.2021

• Kalnin, KV, et al.Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models.NPJ vaccines.2021

• Thomas, A, et al.Establishment of Monoclonal Antibody Standards for Quantitative Serological Diagnosis of SARS-CoV-2 in Low Incidence Settings.Open Forum Infectious Diseases.2021

• Xu, C, et al.Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro.Pathogens.2021

• Morotti, D, et al.Molecular Pathology Analysis of SARS-CoV-2 in Syncytiotrophoblast and Hofbauer Cells in Placenta from a Pregnant Woman and Fetus with COVID-19.Pathogens (Basel, Switzerland).2021

• Falleni, M, et al.Endothelial-Mesenchymal Transition in COVID-19 lung lesions.Pathology - Research and Practice.2021

• Putcharoen, O, et al.Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.PloS one.2021

• Frasca, D, et al.Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients.PloS one.2021

• Bläckberg, A, et al.Antibody kinetics and clinical course of COVID-19 a prospective observational study.PloS one.2021

• Prompetchara, E, et al.DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice.PloS one.2021

• Ferreira, VH, et al.Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.PloS one.2021

• Sil, B, et al.AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for COVID-19 (SARS-CoV-2) Explicit IgG Antibody

• Mena, EL, et al.ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection.Proceedings of the National Academy of Sciences of the United States of America.2021

• Wang, Y, et al.The Infectivity and Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom.Research Square.2021

• Schreiber, G, et al.SARS-CoV-2 RBD in vitro evolution parrots and predicts contagious mutation spread.Research Square.2021

• Zhou, Z, et al.Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection.Research Square.2021

• Jin, A, et al.Ultrapotent SARS-CoV-2 neutralizing antibodies effectively block new-emerging mutational variants.Research Square.2021

• Zhang, L, et al.Single-dose immunization with a chimpanzee adenovirus-based vaccine induces sustained and protective immunity against SARS-CoV-2 infection.Research Square.2021

• Cui, J, et al.SUMOylation restrains ACE2 degradation through TOLLIP-mediated selective autophagy to facilitate the host susceptibility to SARS-CoV-2 infection.Research Square.2021

• Chen, CH, et al.Deletion of ER-retention Motif on SARS-CoV-2 Spike Protein Reduces Cell Hybrid During Cell-cell Fusion.Research square.2021

• Díaz, M, et al.Preclinical Evaluation of a Newcastle Disease Virus-Vectored Intranasal SARS-CoV-2 Vaccine.Research Square.2021

• Dou, C, et al.Structure and function analysis of a potent human neutralizing antibody CA521LALA against

• Zhu, F, et al.First report demonstrating the safety and immunogenicity of the SARS-COV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, observer-blind Phase I

• Mahallawi, W, et al.Durability of the humoral immune response in recovered COVID-19 patients.Saudi journal of biological sciences.2021

• Alsayb, M, et al.Prolonged humoral and cellular immunity in COVID-19-recovered patients.Saudi Journal of Biological Sciences.2021

• Mahallawi, WH, et al.Humoral immune responses in hospitalized COVID-19 patients.Saudi journal of biological sciences.2021

• Mahallawi, W, et vitro cell culture model of human nasal-associated lymphoid tissue(NALT) to evaluate the humoral immune response to SARS- CoV-2 spike proteins.Saudi Journal of Biological Sciences.2021

• Hao, W, et al.Binding of the SARS-CoV-2 Spike Protein to Glycans.Science bulletin.2021

• Li, X, et al.Risk factors and on-site simulation of environmental transmission of SARS-CoV-2 in the largest wholesale market of Beijing, China.Science of The Total Environment.2021

• Mojsoska, B, et al.Rapid SARS-CoV-2 Detection Using Electrochemical Immunosensor.Sensors (Basel, Switzerland).2021

• Li, Y, et al.Magnetic graphene quantum dots facilitate closed-tube one-step detection of SARS-CoV-2 with ultra-low field NMR relaxometry.Sensors and actuators. B, Chemical.2021

• Gao, L, et al.The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity.Signal transduction and targeted therapy.2021

• Wu, Y, et al.RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation.Signal transduction and targeted therapy.2021

• Tian, L, et al.Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19.SSRN Electronic Journal.2021

• Li, Q, et al.No Higher Infectivity But Immune Escape of SARS-CoV-2 501Y.V2 Variants.SSRN Electronic Journal.2021

• Wu, F, et al.Generation of WAe001-A-58 human embryonic stem cell line with inducible expression of the SARS-CoV-2 nucleocapsid protein.Stem Cell Research.2021

• Li, C, et al.Synthesis of polystyrene-based fluorescent quantum dots nanolabel and its performance in H5N1 virus and SARS-CoV-2 antibody sensing.Talanta.2021

• Posch, W, et al.C5aR inhibition of non-immune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia.The Journal of allergy and clinical immunology.2021

• Zhang, HL, et al.Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.The Journal of biological chemistry.2021

• Ogega, CO, et al.Durable SARS-CoV-2 B cell immunity after mild or severe disease.The Journal of clinical investigation.2021

• Woldemeskel, BA, et al.SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.The Journal of clinical investigation.2021

• Zhuang, Z, et al.Mapping and role of T cell response in SARS-CoV-2-infected mice.The Journal of experimental medicine.2021

• Ouwendijk, WJD, et al.Neutrophil extracellular traps persist at high levels in the lower respiratory tract of critically ill COVID-19 patients.The Journal of infectious diseases.2021

• Cunningham, JL, et al.Anti-SARS-CoV2 antibody responses in serum and cerebrospinal fluid of COVID-19 patients with neurological symptoms.The Journal of infectious diseases.2021

• Haymond, A, et al.Viral Neutralization is Durable in Asymptomatic COVID-19 for at least 60 Days.The Journal of infectious diseases.2021

• Bao, L, et al.Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats.The Journal of infectious diseases.2021

• Jeffery-Smith, A, et al.Infection and transmission of SARS-CoV-2 in London care homes reporting no cases or outbreaks of COVID-19: prospective observational cohort study, England 2020.The Lancet Regional Health - Europe.2021

• Park, BK, et al.MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.Theranostics.2021

• Veeck, CM, et al.Studies on the Intracellular Trafficking of SARS-CoV-2 Structural Proteins S, M and E.Thesis.2021

• Kim, S, et al.Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins.Thesis.2021

• Marsh, GA, et al.In vitro Characterisation of SARS-CoV-2 and Susceptibility of Domestic Ferrets (Mustela putorius furo).Transboundary and emerging diseases.2021

• Vandeberg, P, et al.Brief report: Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.Transfusion.2021

• Su, QD, et al.Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.Vaccine.2021

• Kandeil, A, et al.Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies.Vaccines.2021

• Ji, R, et al.BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19.Vaccines.2021

• Bösmüller, H, et al.The pulmonary pathology of COVID-19.Virchows Archiv : an international journal of pathology.2021

• Zhao, B, et al.Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study.Virologica Sinica.2021

• Wang, B, et al.Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation.Virologica Sinica.2021

• Hashizume, M, et al.Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro.Viruses.2021

• Lockbaum, GJ, et al.Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.Viruses.2021

• Rusanen, J, et al.A 10-Minute \"Mix and Read\" Antibody Assay for SARS-CoV-2.Viruses.2021

• Fink, K, et al.Amantadine Inhibits SARS-CoV-2 In Vitro.Viruses.2021

• Makdasi, E, et al.Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope.Viruses.2021

• Park, E, et al.The Spike Glycoprotein of SARS-CoV-2 Binds to β1 Integrins Expressed on the Surface of Lung Epithelial Cells.Viruses.2021

• Allnoch, L, et al.Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters.Viruses.2021

• Cao, L,et al.De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.Science (New York, N.Y.).2020

• Hansen, J,et al.Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.Science (New York, N.Y.).2020

• Chandrashekar, A,et al.SARS-CoV-2 infection protects against rechallenge in rhesus macaques.Science (New York, N.Y.).2020

• Chan, KK,et al.Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.Science.2020

• Gu, H,et al.Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.Science.2020

• Deng, W,et al.Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.Science.2020

• Brouwer, PJM,et al.Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.Science.2020

• Renhong Yan,et al.Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2.Science.2020

• Lamers, MM,et al.SARS-CoV-2 productively infects human gut enterocytes.Science.2020

• Rockx, B,et al.Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.Science.2020

• Yu, J,et al.DNA vaccine protection against SARS-CoV-2 in rhesus macaques.Science.2020

• Xiangyang Chi,et al.A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.Science.2020

• Zhe Lv,et al.Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent theraprutic antibody.Science.2020

• Bin Ju,et al.Human neutralizing antibodies elicited by SARS-CoV-2 infection.Nature.2020

• Linlin Bao,et al.The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice.Nature.2020

• Dora Pinto,et al.Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.Nature.2020

• Bojkova, D,et al.Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.Nature.2020

• Liu, L,et al.Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike.Nature.2020

• Ke, Z,et al.Structures and distributions of SARS-CoV-2 spike proteins on intact virions.Nature.2020

• Meckiff, B,et al.Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19.Cell.2020

• Piccoli, L,et al.Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.Cell.2020

• Yurkovetskiy, L,et al.Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.Cell.2020

• Du, S,et al.Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy.Cell.2020

• Li, W,et al.High potency of a bivalent human VH domain in SARS-CoV-2 animal models.Cell.2020

• Cao, Y,et al.Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\' B cells.Cell.2020

• Wrapp, Daniel,et al.Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.Cell.2020

• Sun, J,et al.Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.Cell.2020

• Wang, H,et al.Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.Cell.2020

• Dai, L,et al.A universal design of betacoronavirus vaccines against COVID-19, MERS and SARS.Cell.2020

• Li, Q,et al.The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.Cell.2020

• Zhang, N,et al.A thermostable mRNA vaccine against COVID-19.Cell.2020

• Chi, X,et al.Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain.Nature communications.2020

• Rudberg, AS,et al.SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.Nature Communications .2020

• Simon, D,et al.Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion.Nature Communications .2020

• Jiang, HW,et al.SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.Nature Communications .2020

• Wang, C,et al.A human monoclonal antibody blocking SARS-CoV-2 infection.Nature Communications .2020

• Ou, X,et al.Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.Nature Communications .2020

• Deng, W,et al.Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in Rhesus macaques.Nature Communications .2020

• Smith, TRF,et al.Immunogenicity of a DNA vaccine candidate for COVID-19.Nature Communications .2020

• Noy-Porat, T,et al.A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes.Nature Communications .2020

• Zhao, H,et al.A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2.Nature Communications .2020

• Feng, L,et al.An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques.Nature Communications .2020

• Ripperger, T,et al.Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low Prevalence Communities and Reveal Durable Humoral Immunity..Immunity.2020

• Ni, L,et al.Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals.Immunity.2020

• Laczkó, D,et al.A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice.Immunity.2020

• Tostanoski, LH,et al.Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.Nature Medicine.2020

• Long, QX,et al.Antibody responses to SARS-CoV-2 in patients with COVID-19.Nature Medicine.2020

• Amanat F,et al.A serological assay to detect SARS-CoV-2 seroconversion in humans.Nature Medicine.2020

• McCallum, M,et al.Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation.Nat. Struct. Mol. Biol.2020

• Wu, Y,et al.Identification of Human Single-Domain Antibodies against SARS-CoV-2.Cell Host Microbe.2020

• Dieterle, M,et al.A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition.Cell Host & Microbe.2020

• Stanifer, ML,et al.Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells.Cell Rep.2020

• Zhang, H,et al.Activation of Peroxiredoxin 1 by Fluvastatin Effectively Protects from Inflammation and SARS-CoV-2.Cell Metabolism.2020

• Huibin LvCross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections.Cell Reports.2020

• Yi, C,et al.Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.Cell. Mol. Immunol.2020

• Schurink, B,et al.Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study.The Lancet Microbe.2020

• Matschke, J,et al.Neuropathology of patients with COVID-19 in Germany: a post-mortem case series.Lancet Neurol.2020

• Xiao, F,et al.Evidence for gastrointestinal infection of SARS-CoV-2.Gastroenterology.2020

• Seo, G,et al.Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor.ACS Nano.2020

• Su, H,et al.Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.Kidney Int..2020

• Ye, L,et al.Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor.Cellular & Molecular Immunology.2020

• Bing ZhaoRecapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Organoids.Protein&Cell.2020

• Chia, WN,et al.Serological differentiation between COVID-19 and SARS infections.Emerg Microbes Infect.2020

• Sun B,et al.Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients.Emerg Microbes Infect..2020

• Shan-Meng Lin,et al.Structure-Based Stabilization of Non-native Protein-Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design.J. Med. Chem.2020

• Liu, X,et al.Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction.Acta Pharm Sin B.2020

• Liu, X,et al.Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19.Acta Pharm Sin B.2020

• Okba, NMA,et al.Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients.Emerging Infect. Dis.2020

• Sangeun Jeon,et al.Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs.Antimicrob Agents Chemother.2020

• Zeng, W,et al.Biochemical characterization of SARS-CoV-2 nucleocapsid protein.Biochemical and Biophysical Research Communications.2020

• Fujita, R,et al.Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system.Biochemical and Biophysical Research Communications.2020

• Chen, Z,et al.A DNA Aptamer Based Method for Detection of SARS-CoV-2 Nucleocapsid Protein.Virol Sin.2020

• Huang, S,et al.Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development.Biomedical Journal.2020

• Musarrat, F,et al.The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARSCoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections.J Med Virol.2020

• Pu, T,et al.Evaluate Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity by Pseudoviral Particles.J. Med. Virol.2020

• Carnevale, S,et al.Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD-19 patient with diarrhea.J. Med. Virol.2020

• Zeng, X,et al.Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy.Antibody Therapeutics.2020

• Sobrevilla, JMV;¿ Por qué los pacientes con diabetes o hipertensión son más susceptibles a tener COVID-19?.Conference.2020

• Harcourt, Jennifer,et al.Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States.Emerging Infectious Diseases.2020

• Feng, Siqin,et al.Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases.2020

• Zeng, X,et al.Molecular Detection of SARS-CoV-2 in Formalin Fixed Paraffin Embedded Specimens.JCI Insight.2020

• Larsen, CP,et al.Collapsing Glomerulopathy in a Patient With Coronavirus Disease 2019 (COVID-19).Kidney Int Rep.2020

• Simon, D,et al.Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 infection.Research Square.2020

• Kanjanasirirat, P,et al.High-Content Screening of Thai Medicinal Plants Reveals Boesenbergia rotunda Extract and its Component Panduratin A as Anti-SARS-CoV-2 Agents.Research Square.2020

• Yang, J,et al.Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.Research Square.2020

• Bdr-Eldeen, O;What we should understand about SARS-COV-2

• Ravichandran, Supriya,et al.Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits.Science Translational Medicine.2020

• Zhou, R,et al.Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.SSRN Journal.2020

• Cheng, Y,et al.Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.SSRN Journal.2020

• 彭浩然,et al.上海 2 株严重急性呼吸综合征冠状病毒 2 的分离与鉴定.第二军医大学学报.2020

• Yu, P,et al.Age-related rhesus macaque models of COVID-19.Anim Models Exp Med.2020

• Turista, D,et al.Distribution of COVID-19 and Phylogenetic Tree Construction of SARS-CoV-2 in Indonesia.J. Pure Appl. Microbiol.2020

• Belete, T;A review on Promising vaccine development progress for COVID-19 disease.Vacunas.2020

• Gan, JH;Discovery of small molecule therapeutics for the Middle Eastern respiratory syndrome-coronavirus (MERS-CoV).Thesis.2020

• Wang, C,et al.Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.EBioMedicine.2020

• Lei, H,et al.SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patients.Influenza Other Respir Viruses.2020

• Hernandez, J,et al.Dodging COVID-19 infection: Low expression and localization of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) in Mesenchymal Stem Cells derived from human umbilical cord (hUC-MSCs)..Research Square.2020

• Wu, S,et al.A single dose of an adenovirus-vectored vaccine provides complete protection of the upper and lower respiratory tracts against SARS-CoV-2 challenge.Research Square.2020

• Liu, L;Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: A case report.Research Square.2020

• Ren, L,et al.The Kinetics of Humoral Response and its Relationship with the Disease Severity in COVID-19.Research Square.2020

• Tang, X,et al.Spike protein up-regulates inflammatory axis of both thromboinflammation and leukotriene in severe COVID-19.Research Square.2020

• Zhang, X,et al.Engineering mesenchymal stem cells with neutralizing and anti- inflammation dual-capability against SARS-CoV-2 infection.Research Square.2020

• Ahmadivand, A,et al.Femtomolar-level detection of SARS-CoV-2 spike proteins using toroidal plasmonic metasensors.arXiv preprint.2020

• 彭浩然,et al.严重急性呼吸综合征冠状病毒 2 假病毒的制备及验证.第二军医大学 .2020

• Ratajczak, MZ,et al.SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45- Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.Stem Cell Rev Rep.2020

• Hu, J,et al.Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.Genes & Diseases.2020

• Xu, L,et al.COVID-19-like symptoms observed in Chinese tree shrews infected with SARS-CoV-2.Zool Res.2020

• Wang, Y,et al.SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen.J. Med. Virol.2020

• Chiuppesi, F,et al.Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform.Res Sq.2020

• Kumar, D,et al.Prospective Observational Study of Screening Asymptomatic Healthcare Workers for SARS-CoV-2 at a Canadian Tertiary Care Center.medRxiv.2020

• Cate, D,et al.Antibody Screening Results for Anti-Nucleocapsid Antibodies Towards the Development of a SARS-CoV-2 Nucleocapsid Protein Antigen Detecting Lateral Flow Assay.ChemRxiv.2020

• Feng, Z,et al.Detection of the SARS-CoV-2 Nucleocaspid Protein (NP) Using Immunohistochemistry.BIO-PROTOCOL.2020

• Tosif, S,et al.Immune responses to SARS-CoV-2 in children of parents with symptomatic COVID-19.Research Square.2020

• Brocato, RL,et al.Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.Research Square.2020

• Gorshkov, K,et al.Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis.ACS Nano.2020

• Tan, X,et al.Rapid and quantitative detection of SARS-CoV-2 specific IgG for convalescent serum evaluation.Biosensors and Bioelectronics.2020

• Al-Dalahmah, O,et al.Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage.Acta Neuropathol Commun.2020

• McAndrews, KM,et al.Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications on COVID-19 immunity.JCI Insight.2020

• van Tol, S,et al.Accurate Serology for SARS-CoV-2 and common Human Coronaviruses using a Multiplex Approach.Emerg Microbes Infect.2020

• Li, Y,et al.SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig.J. Virol..2020

• Wang, N,et al.Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.Phytomedicine.2020

• Saha, R,et al.Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19.Front. Pharmacol..2020

• Mirzaei, R,et al.Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.Int. Immunopharmacol..2020

• Xiao, C,et al.Human post-infection serological response to the spike and nucleocapsid proteins of SARS-CoV-2.Influenza Other Respir Viruses.2020

• Wheeler, SE,et al.Evaluation of SARS-CoV-2 prototype serologic test in hospitalized patients.Clin. Biochem.2020

• Li, N,et al.Molecular diagnosis of COVID‑19: Current situation and trend in China (Review).Exp Ther Med.2020

• Yang, R,et al.Development and effectiveness of Pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro.Biosaf Health.2020

• Liu, L,et al.Subunit Nanovaccine with Potent Cellular and Mucosal Immunity for COVID-19.ACS Appl. Bio Mater..2020

• Wang, G,et al.Degradation of SARS-CoV-2 Receptor ACE2 by Tobacco Carcinogens.SSRN Journal.2020

• Liu, Z,et al.The recombinant subunit vaccine RBD-Fc, consisting of SARS-CoV-2 RBD and human IgG Fc as an immunopotentiator, elicits robust neutralizing antibody responses against SARS-CoV-2 infection.Research Square.2020

• Azad, T,et al.Nanoluciferase complementation-based biosensor reveals the importance of N- linked glycosylation of SARS-CoV-2 Spike for viral entry.Research Square.2020

• Grant, BD,et al.A SARS-CoV-2 Coronavirus Nucleocapsid Protein Antigen-Detecting Lateral Flow Assay.ChemRxiv.2020

• Renn, A,et al.Fruitful neutralizing antibody pipeline brings hope to defeat SARS-Cov-2.Trends in Pharmacological Sciences.2020

• Ko, M,et al.Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells.J. Med. Virol.2020

• Hsu, A,et al.Placental SARS-CoV-2 in a Pregnant Woman with Mild COVID-19 Disease.J. Med. Virol.2020

• Ko, CJ,et al.Perniosis during the COVID-19 pandemic: Negative Anti-SARS-CoV-2 Immunohistochemistry in Six Patients and Comparison to Perniosis Before the Emergence of SARS-CoV-2.J. Cutan. Pathol..2020

• Schasfoort, R,et al.Presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during CoViD-19 infection.Research Square.2020

• pandolfi, l,et al.Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.Research Square.2020

• Gupta, Y,et al.Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening and in vitro assays.Research Square.2020

• Zeng, C,et al.Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In Vivo.Adv. Mater. Weinheim.2020

• Yu, J,et al.Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition.Blood.2020

• Schäfer, R,et al.Human Mesenchymal Stromal Cells are resistant to SARS-CoV-2 Infection under Steady State, Inflammatory Conditions and in the Presence of SARS-CoV-2 infected Cells.Stem Cell Reports.2020

• Xiong, HL,et al.Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.Emerg Microbes Infect.2020

• Zhang, Q,et al.A serological survey of SARS-CoV-2 in cat in Wuhan.Emerg Microbes Infect.2020

• Gianotti, R,et al.Similarities in Cutaneous Histopathological Patterns between COVID-19-positive and COVID-19 High-risk Patients with Skin Dermatosis.Acta Derm. Venereol..2020

• Azad, T,et al.Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization.Membranes (Basel).2020

• McGregor, R,et al.Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New Zealand.PeerJ.2020

• Diorio, C,et al.Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.Pediatr Blood Cancer.2020

• Demers-Mathieu, V,et al.Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk.J Perinatol.2020

• Lee, SY,et al.A Novel Neutralizing Antibody Targeting Receptor Binding Domain of SARS-CoV-2.Research Square.2020

• Cantera, J,et al.Screening Antibodies Raised Against the Spike Glycoprotein of SARS-CoV-2 to Support the Development of Rapid Antigen Assays.ChemRxiv.2020

• Norman, M,et al.Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19.Nature biomedical engineering.2020

• Pierce, CA,et al.Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients.Science translational medicine.2020

• Segalés, J,et al.Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.Proceedings of the National Academy of Sciences of the United States of America.2020

• Cazares, LH,et al.Development of a parallel reaction monitoring (PRM) mass spec-trometry-assay for the detection of SARS-CoV-2 spike glycoprotein and nucleoprotein.Anal. Chem..2020

• Lee, S,et al.Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.Emerg Microbes Infect.2020

• Jin, W,et al.The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica.International journal of biological macromolecules.2020

• Rayner, JO,et al.AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication.Biochemical pharmacology.2020

• Yu, S,et al.Glycyrrhizic Acid Exerts Inhibitory Activity against the Spike Protein of SARS-CoV-2.Phytomedicine.2020

• Omotuyi, IO,et al.Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS-CoV-2 drug targets: in vitro validation of furin inhibition.Phytother Res.2020

• Liu, X,et al.Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.Vaccine.2020

• Ko, CJ,et al.Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.Journal of cutaneous pathology.2020

• Oishee, M,et al.COVID-19 diagnostics: Current and Prospective Tools.Journal of Translational Autoimmunity.2020

• Dong, J,et al.Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2.Research Square.2020

• Tao, W,et al.Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.Medicine in Microecology.2020

• Jacob, F,et al.Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium.Cell Stem Cell.2020

• Liu, Q,et al.Pathological changes in the lungs and lymphatic organs of twelve COVID-19 autopsy cases.National Science Review.2020

• Zeng, H,et al.The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series.Signal Transduct Target Ther.2020

• Lee, J,et al.A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).Biosensors and Bioelectronics.2020

• Cady, N,et al.Multiplexed detection and quantification of human antibody response to COVID-19 infection using a plasmon enhanced biosensor platform.Biosensors and Bioelectronics.2020

• Rao, L,et al.Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines.Proc Natl Acad Sci U S A.2020

• Bosco-Lauth, AM,et al.Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats.Proc Natl Acad Sci U S A.2020

• Chen, X,et al.Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening.Acta Pharmaceutica Sinica B.2020

• Li, H,et al.Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays.Emerg Microbes Infect.2020

• Luetkens, T,et al.Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.Blood Adv.2020

• Hopfer, H,et al.Hunting coronavirus by transmission electron microscopy - a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues.Histopathology.2020

• Alandijany, TA,et al.Development and Optimization of In-house ELISA for Detection of Human IgG Antibody to SARS-CoV-2 Full Length Spike Protein.Pathogens.2020

• Barisione, E,et al.Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems.Virchows Arch.2020

• Huang, PH,et al.Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain.Hum Vaccin Immunother.2020

• Torrente-Rodríguez, RM,et al.SARS-CoV-2 RapidPlex: A Graphene-based Multiplexed Telemedicine Platform for Rapid and Low-Cost COVID-19 Diagnosis and Monitoring.Matter.2020

• Rosenke, K;Hansen, F,et al.Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model.Research Square.2020

• Bullen, CK,et al.Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2.ALTEX.2020

• Kim, SY,et al.Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.Antiviral Res.2020

• Takeda, Y,et al.Saxifraga spinulosa-Derived Components Rapidly Inactivate Multiple Viruses Including SARS-CoV-2.Viruses.2020

• Yee, JL,et al.SARS-CoV-2 surveillance for a non-human primate breeding research facility.J. Med. Primatol..2020

• Li, Z,et al.Cell-Mimicking Nanodecoys Protect Lung Cells by Neutralization of SARS-CoV-2 Spike Proteins.Research Square.2020

• Wang, Z,et al.COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury.Am. J. Respir. Crit. Care Med..2020

• Tzankov, A,et al.Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic.Virchows Arch..2020

• Chen, W,et al.Reducing false negatives in COVID-19 testing by using microneedle-based oropharyngeal swabs.Matter.2020

• Chandrasekar, SS,et al.A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.J. Virol..2020

• Prasad, ASV;Local Immunity Concept in the Context of the Novel Corona Viral Infection: A Consideration.bioRxiv.2020

• Khan, S,et al.Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray.BioRxiv.2020

• Thornburg, N,et al.Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient.bioRxiv.2020

• Chunyun Sun,et al.SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development.bioRxiv.2020

• Milewska, A,et al.HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV.bioRxiv.2020

• Wang, C,et al.Lectin-like Intestinal Defensin Inhibits 2019-nCoV Spike binding to ACE2.bioRxiv.2020

• Li, Y,et al.Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1.bioRxiv.2020

• Xiong, H,et al.Robust neutralization assay based on SARS-CoV-2 S-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressed BHK21 cells.bioRxiv.2020

• Zhang, Q,et al.SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation.bioRxiv.2020

• Zhang, Y,et al.Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry.bioRxiv.2020

• Liu, Y,et al.Functional and Genetic Analysis of Viral Receptor ACE2 Orthologs Reveals Broad Potential Host Range of SARS-CoV-2.bioRxiv.2020

• Tan, X,et al.Rapid and quantitative detection of COVID-19 markers in micro-liter sized samples.bioRxiv.2020

• Zhu, Y,et al.Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals.bioRxiv.2020

• Walter, JD,et al.Synthetic nanobodies targeting the SARS-CoV-2 receptor-binding domain.BioRxiv.2020

• De Assis, RR,et al.Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Plasma using a Coronavirus Antigen Microarray.BioRxiv.2020

• Chi X,et al.Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain.bioRxiv.2020

• Kim, SY,et al.Glycosaminoglycan binding motif at S1/S2 proteolytic cleavage site on spike glycoprotein may facilitate novel coronavirus (SARS-CoV-2) host cell entry.bioRxiv.2020

• Si L,et al.Human organs-on-chips as tools for repurposing approved drugs as potential influenza and COVID19 therapeutics in viral pandemics.bioRxiv.2020

• Liu L,et al.SARS-CoV-2 spike protein binds heparan sulfate in a length-and sequence-dependent manner.bioRxiv.2020

• Zha L,et al.Development of a COVID-19 vaccine based on the receptor binding domain displayed on virus-like particles.bioRxiv.2020

• Romano, M,et al.An engineered stable mini-protein to plug SARS-Cov2 Spikes.bioRxiv.2020

• Liu, Y,et al.Functional and Genetic Analysis of Viral Receptor ACE2 Orthologs Reveals a Broad Potential Host Range of SARS-CoV-2.bioRxiv.2020

• De Assis, RR,et al.Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen Microarray.BioRxiv.2020

• Hedde, PN,et al.A Modular Microarray Imaging System for Highly Specific COVID-19 Antibody Testing.bioRxiv.2020

• Ghazizadeh, Z,et al.Androgen regulates SARS-CoV-2 receptor levels and is associated with severe COVID-19 symptoms in men.bioRxiv.2020

• Finch, CL,et al.Characteristic and quantifiable COVID-19-like abnormalities in CT-and PET/CT-imaged lungs of SARS-CoV-2-infected crab-eating macaques (Macaca fascicularis).bioRxiv.2020

• Cai, Y,et al.Distinct conformational states of SARS-CoV-2 spike protein.bioRxiv.2020

• Zang, J,et al.Immunization with the receptor–binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement.bioRxiv.2020

• Zost, SJ,et al.Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.bioRxiv.2020

• Zhang, Y,et al.The ORF8 Protein of SARS-CoV-2 Mediates Immune Evasion through Potently Downregulating MHC-I.bioRxiv.2020

• Corbett, K,et al.SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness.bioRxiv.2020

• Yang, Y,et al.The utility of native MS for understanding the mechanism of action of repurposed therapeutics in COVID-19: heparin as a disruptor of the SARS-CoV-2 interaction with its host cell receptor.bioRxiv.2020

• Daly, J,et al.Neuropilin-1 is a host factor for SARS-CoV-2 infection.bioRxiv.2020

• Liu, D,et al.Ultra-sensitive nanozyme-based chemiluminescence paper test for rapid diagnosis of SARS-CoV-2 infection.bioRxiv.2020

• Mesci, P,et al.Sofosbuvir protects human brain organoids against SARS-CoV-2.bioRxiv.2020

• Bosco-Lauth, A,et al.Pathogenesis, transmission and response to re-exposure of SARS-CoV-2 in domestic cats.bioRxiv.2020

• Yao, D,et al.Human H-ferritin presenting RBM of spike glycoprotein as potential vaccine of SARS-CoV-2.bioRxiv.2020

• Liu, L,et al.A translatable subunit nanovaccine for COVID-19.Chem Rxiv.2020

• Song, Y,et al.Discovery of Aptamers Targeting Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein.ChemRxiv.2020

• Jiang, H,et al.Global profiling of SARS-CoV-2 specific IgG/IgM responses of convalescents using a proteome microarray.medRxiv.2020

• Bo Diao,et al.Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.medRxiv.2020

• Linlin Bao,et al.Reinfection could not occur in SARS-CoV-2 infected rhesus macaques.medRxiv.2020

• Linlin Bao,et al.Rhesus macaques can be effectively infected with SARS-CoV-2 via ocular conjunctival route.medRxiv.2020

• Ke Wang,et al.SARS-CoV-2 invades host cells via a novel route: CD147-spike protein.medRxiv.2020

• Feng, Z,et al.The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes.medRxiv.2020

• Wei, C,et al.Cholesterol Metabolism--Impact for SARS-CoV-2 Infection Prognosis, Entry, and Antiviral Therapies.medRxiv.2020

• McAndrews, KM,et al.Identification of IgG antibody response to SARS-CoV-2 spike protein and its receptor binding domain does not predict rapid recovery from COVID-19.medRxiv.2020

• Norman, M,et al.Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients.medRxiv.2020

• Randad, PR,et al.COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva.medRxiv.2020

• Rosenberg, ES,et al.Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York.medRxiv.2020

• Phipps, WS,et al.SARS-CoV-2 Antibody responses do not predict COVID-19 disease severity.medRxiv.2020

• Chakraborty, S,et al.Symptomatic SARS-CoV-2 infections display specific IgG Fc structures.medRxiv.2020

• Rosendal, E,et al.Detection of asymptomatic SARS-CoV-2 exposed individuals by a sensitive S-based ELISA..medRxiv.2020

• Mittal, A,et al.COVID-19 Pandemic: Insights into Structure, Function, and hACE2 Receptor Recognition by the SARS-CoV-2.preprints.2020

• Liu, L,et al.Potent Neutralizing Monoclonal Antibodies Directed to Multiple Epitopes on the SARS-CoV-2 Spike.bioRxiv.2020

• Beddingfield, B;Iwanaga, N,et al.The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection.bioRxiv.2020

• Salazar, E,et al.Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 In Vitro Virus Neutralization in Convalescent Plasma.bioRxiv.2020

• Hanson, QM,et al.Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay.bioRxiv.2020

• Giobbe, G,et al.SARS-CoV-2 infection and replication in human fetal and pediatric gastric organoids.bioRxiv.2020

• Wang, N,et al.Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of COVID-19 Spike pseudotype virus.bioRxiv.2020

• Liu, J,et al.Engineered human mesenchymal stem cells as new vaccine platform for COVID-19.bioRxiv.2020

• Hu, J,et al.The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera.bioRxiv.2020

• Klimstra, W,et al.SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patients.bioRxiv.2020

• den Hartog, G,et al.SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence.medRxiv.2020

• Yahalom-Ronen, Y,et al.A single dose of recombinant VSV-ΔG-spike vaccine provides protection against SARS-CoV-2 challenge.bioRxiv.2020

• Mulgaonkar, N,et al.Bcr-Abl tyrosine kinase inhibitor imatinib as a potential drug for COVID-19.bioRxiv.2020

• Blair, R;Vaccari, M,et al.ARDS and Cytokine Storm in SARS-CoV-2 Infected Caribbean Vervets.bioRxiv.2020

258. Walker, S,et al.SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patients.bioRxiv.2020

• Stukalov, A,et al.Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV.bioRxiv.2020

• Liu, T,et al.High-Accuracy Multiplexed SARS-CoV-2 Antibody Assay with Avidity and Saliva Capability on a Nano-Plasmonic Platform.bioRxiv.2020

• Steiner, D,et al.Array-based analysis of SARS-CoV-2, other coronaviruses, and influenza antibodies in convalescent COVID-19 patients.bioRxiv.2020

• Ozono, S,et al.Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry.bioRxiv.2020

• Zhang, J,et al.Cross-reactivity of neutralizing antibody and its correlation with circulating T follicular cells in recovered COVID-19 individuals.medRxiv.2020

• Zhou, D,et al.Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.bioRxiv.2020

• Zang, R,et al.Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.bioRxiv.2020

• Zhang, G,et al.Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD.bioRxiv.2020

• Baker, AN,et al.The SARS-COV-2 spike protein binds sialic acids, and enables rapid detection in a lateral flow point of care diagnostic device.PrePrint.2020

• Rice, A,et al.A Next Generation Bivalent Human Ad5 COVID-19 Vaccine Delivering Both Spike and Nucleocapsid Antigens Elicits Th1 Dominant CD4+, CD8+ T-cell and Neutralizing Antibody Responses.bioRxiv.2020

• Clausen, TM,et al.SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.bioRxiv.2020

• Li, T,et al.A potent synthetic nanobody targets RBD and protects mice from SARS-CoV-2 infection.bioRxiv.2020

• Pomplun, S;Jbara, M,et al.De Novo Discovery of High Affinity Peptide Binders for the SARS-CoV-2 Spike Protein.bioRxiv.2020

• Chiuppesi, F,et al.Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine.bioRxiv.2020

• Acharya, P,et al.A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies.bioRxiv.2020

• Zhang, L,et al.The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity.bioRxiv.2020

• Onodi, F,et al.SARS-CoV-2 induces activation and diversification of human plasmacytoid pre-dendritic cells.bioRxiv.2020

• Du, S,et al.Structures of potent and convergent neutralizing antibodies bound to the SARS-CoV-2 spike unveil a unique epitope responsible for exceptional potency.bioRxiv.2020

• Golden, J,et al.Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease.bioRxiv.2020

• Langellotto, F,et al.A rapidly adaptable biomaterial vaccine for SARS-CoV-2.bioRxiv.2020

• Xiao, X,et al.Identification of potent and safe antiviral therapeutic candidates against SARS-CoV-2.bioRxiv.2020

• Xu, C,et al.Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM.bioRxiv.2020

• Herrmann, A,et al.A Targeted Vaccine against COVID-19: S1-Fc Vaccine Targeting the Antigen-Presenting Cell Compartment Elicits Protection against SARS-CoV-2 Infection.bioRxiv.2020

• Routhu, N,et al.Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response.bioRxiv.2020

• Ke, Z,et al.Structures, conformations and distributions of SARS-CoV-2 spike protein trimers on intact virions.bioRxiv.2020

• Zhang, Y,et al.Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins.bioRxiv.2020